Nearly 60% of rheumatology patients struggle to afford treatment

September 19, 2019
Although 90% of patients with rheumatic diseases have health insurance, 57.13% report struggling to afford their medication, with one-quarter paying…
In the Journals

Patient-reported outcome measures with Skindex may yield more comprehensive data

September 19, 2019
Relying primarily on patient global assessments falls short in determining comprehensive disease severity, but by adding the Skindex instrument or…
In the Journals

Adalimumab, IBI303 biosimilar demonstrate comparable safety, efficacy in AS

September 19, 2019
IBI303, a biosimilar to adalimumab developed by Chinese biopharmaceutical company Innovent Biologics, is comparable in safety and efficacy to the…
FDA NewsPerspective

Gazyva receives FDA breakthrough therapy designation for lupus nephritis

September 18, 2019
The FDA has granted Gazyva breakthrough therapy designation for the treatment of adult patients with lupus nephritis, according to a Genentech press…
Editorial

Rheumatology in the Blink of an Eye

Healio Rheumatology, September 2019
Leonard H. Calabrese, DO
I am feeling rather nostalgic at the moment. Perhaps it’s just because summer is drawing to a close and autumn is on its way. No? Perhaps…
Education Lab

Essential Strategies for Managing Psoriatic Arthritis

Healio Rheumatology, September 2019
Learning Objectives: Upon completion of this educational activity, the participant should be able to:
Cover Story

Out for Blood: Biomarkers Paving the Road to Personalized Medicine for Rheumatic Diseases

Healio Rheumatology, September 2019
There are endless idioms about blood. It is thicker than water, but one cannot get it from a stone. Truman Capote wrote about the cold version, rock…
Meeting News

Infusion center patient experience growing more complex

September 18, 2019
GRAND RAPIDS, Mich. — As infusion centers have grown in complexity throughout the years, so too has the patient experience in these suites…
In the Journals

Infusion reactions to rituximab more significant in SLE than other diseases

September 17, 2019
Infusion reaction rates to rituximab may be more significant among patients with systemic lupus erythematosus than other diseases, according to…
Meeting News

Managers urged to broaden ‘recruitment parameters’ amid rheumatology shortage

September 17, 2019
GRAND RAPIDS, Mich. — In light of a worsening rheumatologist shortage in the United States, practices that wish to not only recruit physicians…
In the Journals

Newly diagnosed cases of AS at increased risk for IMIDs, lower risk for RA

September 16, 2019
Newly diagnosed patients with ankylosing spondylitis in Taiwan demonstrate increased risks for multiple immune-mediated inflammatory diseases…
Meeting News

Minimizing decision ‘uncertainty’ key to successful practice management

September 16, 2019
GRAND RAPDIS, Mich. — Successful management in rheumatology practices requires both evidence-based approaches and critical thinking, in order…
Meeting News

Generation Z ‘coming soon to a workforce near you’ – Are you ready?

September 13, 2019
GRAND RAPIDS, Mich. — Workplaces and managers who may or may not have just grown acquainted with — and successfully integrated —…
In the Journals

Patients with low-disease RA on tofacitinib, methotrexate can safely withdraw methotrexate

September 12, 2019
Patients with rheumatoid arthritis who achieve low disease activity with tofacitinib plus methotrexate can safely withdraw methotrexate without fear…
Feature

Purdue Pharma tentatively settles opioid lawsuits, others still pending

September 12, 2019
Oxycontin manufacturer Purdue Pharma recently reached a tentative agreement with many of the thousands of plaintiffs involved in a multidistrict…
In the Journals

Stress ‘primary driver’ for fatigue in patients with SLE

September 12, 2019
Although depression and stress are both predictors of fatigue among patients with systemic lupus erythematosus at 1 year, stress is the…
Breaking News

‘Progress being made’ in opioid epidemic, CDC says

September 12, 2019
A CDC spokesperson said provisional data and other reports signify that “progress is being made” in the opioid epidemic. The turnaround…

370 medical groups petition Congress for prior authorization reform

September 11, 2019
The American College of Rheumatology has joined 369 other patient, physician and health care professional groups in calling on Congress to pass a…
In the Journals

Quarter of axial SpA patients attain inactive disease after 6 months on first TNF inhibitor

September 11, 2019
Among patients with axial spondyloarthritis receiving their first TNF inhibitor, 27% achieve inactive disease, defined by the Ankylosing Spondylitis…

Advocates lobby for bills to reform step therapy, expand rheumatology workforce

September 10, 2019
More than 100 patient advocates, including physicians and health professionals from the American College of Rheumatology, took to Capitol Hill this…